Zojwalla Naseem's most recent trade in Olema Pharmaceuticals Inc was a trade of 250,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 106,250 | 106,250 | - | - | Performance Stock Options (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 19 Dec 2025 | 100,000 | 53,997 | - | 28.0 | 2,804,000 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.66 per share. | 19 Dec 2025 | 99,509 | 4,488 | - | 27.7 | 2,752,419 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 19 Dec 2025 | 57,079 | 116,918 | - | 28.0 | 1,599,924 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 50,000 | 156,818 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 19 Dec 2025 | 50,000 | 103,997 | - | 7.0 | 351,000 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.25 per share. | 19 Dec 2025 | 42,818 | 146,815 | - | 15.3 | 652,975 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 42,818 | 112,182 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.25 per share. | 19 Dec 2025 | 40,000 | 173,997 | - | 15.3 | 610,000 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 40,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.93 per share. | 19 Dec 2025 | 12,921 | 103,997 | - | 28.9 | 373,805 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 19 Dec 2025 | 7,182 | 153,997 | - | 7.0 | 50,418 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 7,182 | 206,818 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 14,000 | 112,840 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.87 per share. | 16 Dec 2024 | 14,000 | 129,509 | - | 4.9 | 68,180 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 52,000 | 143,314 | - | 0 | Common Stock | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 14,202 | 115,829 | - | 8.7 | 122,989 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.37 per share. | 09 Dec 2024 | 13,283 | 130,031 | - | 9.4 | 124,462 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 320 | 115,509 | - | 9.4 | 3,005 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.87 per share. | 24 May 2024 | 9,460 | 89,824 | - | 4.9 | 46,070 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 9,460 | 126,840 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.87 per share. | 18 Mar 2024 | 13,700 | 80,364 | - | 4.9 | 66,719 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 13,700 | 136,300 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 25 Jan 2024 | 20,000 | 66,664 | - | 7.0 | 140,400 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 20,000 | 214,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Zojwalla Naseem | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 11 Dec 2023 | 2,900 | 46,664 | - | 7.0 | 20,358 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 2,900 | 234,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 06 Dec 2023 | 13,100 | 43,764 | - | 7.0 | 91,962 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 13,100 | 236,900 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 28,000 | 45,220 | - | 0 | Common Stock | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 20 Nov 2023 | 7,261 | 37,959 | - | 14.8 | 107,681 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 20 Nov 2023 | 7,095 | 30,664 | - | 13.9 | 98,550 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.33 per share. | 20 Nov 2023 | 200 | 37,759 | - | 15.3 | 3,066 | Common Stock |
| Olema Pharma Inc | Naseem Zojwalla | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |